Federal Government Selects Thomson Reuters to Build Tool That Streamlines Comparative Effectiveness Research
ANN ARBOR, Mich., Oct. 14 /PRNewswire/ -- The U.S. Health and Human Services Assistant Secretary for Planning and Evaluation (ASPE) has selected Thomson Reuters to develop a secure, interactive tool that will enable researchers to perform comparative effectiveness studies without the need for professional computer programming.
Comparative effectiveness research (CER) evaluates medical treatments to determine which work best in real-world settings. The American Recovery and Reinvestment Act allocated $1.1 billion to support CER. ASPE administrators believe that a tool that summarizes data files without the need for complicated programming will facilitate CER.
CER studies often depend on aggregating data housed in disparate databases — which requires researchers to start each study from scratch and to process, clean, and format administrative data. This project is designed to build a tool that will simplify that process by making the clinical and administrative health information housed in federal and state databases and the Thomson Reuters MarketScan® databases accessible to researchers using next-generation analytical applications.
The Thomson Reuters MarketScan databases house integrated patient-level data for populations covered by commercial insurance, Medicaid, and Medicare supplemental plans. This information includes inpatient, outpatient, drug, laboratory, and other data reflecting real-world treatment patterns and costs.
As part of the project, Thomson Reuters will develop a pilot system linking multiple healthcare data sources and test it by conducting two high-priority analyses on care delivery options for selected me